Estimaciones de analistas de Wall Street para Nurix Therapeutics, Inc. (NRIX): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-10-08 | $-0.60 | ||
| 2026-07-09 | $-0.81 | $-0.72 | -12.1% |
| 2026-04-08 | $-0.79 | $-0.76 | -3.9% |
| 2026-01-28 | $-0.82 | $-0.84 | +2.4% |
| 2025-10-09 | $-1.03 | $-0.84 | -22.6% |
| 2025-07-09 | $-0.52 | $-0.71 | +26.8% |
| 2025-04-08 | $-0.67 | $-0.72 | +6.9% |
| 2025-01-28 | $-0.75 | $-0.67 | -11.9% |
Ratios de valoración
| Precio / Valor contable | 6.85 |
| EV / EBITDA | -8.13 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Ingresos | $37.4M | $31.1M | $17.8M | $29.8M | $38.6M | $77.0M | $54.5M | $84.0M |
| Coste de Ventas | $40.5M | $45.0M | $66.5M | $116.4M | $184.5M | $189.1M | $221.6M | $18.9M |
| Beneficio Bruto | -$3.1M | -$13.9M | -$48.7M | -$86.7M | -$145.9M | -$112.2M | -$167.1M | $65.1M |
| I+D | $40.5M | $45.0M | $66.5M | $116.4M | $184.5M | $189.1M | $221.6M | $308.2M |
| Generales y Administrativos | $6.7M | $8.3M | $16.3M | $31.2M | $38.0M | $42.9M | $45.9M | $52.7M |
| Gastos Operativos | $6.7M | $8.3M | $16.3M | $31.2M | $38.0M | $42.9M | $45.9M | $350.8M |
| Beneficio Operativo | -$9.7M | -$22.2M | -$65.0M | -$117.9M | -$183.9M | -$155.1M | -$213.0M | -$285.7M |
| EBITDA | -$6.8M | -$19.9M | -$62.8M | -$115.1M | -$176.2M | -$137.8M | -$185.3M | -$244.8M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$8.9M | -$21.5M | -$63.8M | -$117.1M | -$180.4M | -$143.9M | -$193.3M | -$263.7M |
| Impuestos | $507000 | $239000 | -$20.5M | $131000 | 0 | 0 | $270000 | $760000 |
| Beneficio Neto | -$9.4M | -$21.7M | -$43.2M | -$117.2M | -$180.4M | -$143.9M | -$193.6M | -$264.5M |
| BPA | $-0.59 | $-0.56 | $-2.76 | $-2.73 | $-3.71 | $-2.65 | $-2.88 | $-3.05 |
| BPA Diluido | $-0.59 | $-0.56 | $-2.76 | $-2.73 | $-3.71 | $-2.65 | $-2.88 | $-3.05 |
| Acciones en Circulación (Diluidas) | $16.1M | $38.8M | $15.7M | $42.9M | $48.6M | $54.3M | $67.1M | $86.7M |
Precio
| Precio | $25.15 |
| Capitalización | $2.6B |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: BBOT · EYPT · FTRE · KOD · KURA · PHAT · SEPN
Explorar sector: Healthcare · Biotechnology
Más secciones de NRIX: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones